Damaging LXRα variants are linked to liver cholesterol buildup and hepatitis, emphasizing the receptor’s importance in cholesterol sensing and liver function.
Bristol Myers, Cellares sign global CAR-T deal as biopharma companies look to diversify manufacturing partners
Cellares has inked its first international deal with Bristol Myers Squibb, with the cell therapy manufacturer noting it is going through “tremendous tailwinds” from the